Safety and efficacy of controlled-release oxycodone: A systematic literature review

被引:30
作者
Rischitelli, DG
Karbowicz, SH
机构
[1] Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Dept Pharm Serv, Portland, OR 97201 USA
[3] Regence Bluecross Blueshield, Portland, OR USA
来源
PHARMACOTHERAPY | 2002年 / 22卷 / 07期
关键词
D O I
10.1592/phco.22.11.898.33628
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prescriptions for controlled-release oxycodone. a narcotic analgesic, recently contributed to a dramatic increase in pharmacy costs for a large private insurance company To determine whether this agent offered clinical benefits over other available drugs that would justify its significantly greater cost, a systematic review of 16 clinical trials was undertaken. The review suggested that immediate-release and controlled-release preparations of oxycodone have similar efficacy and comparable side effect profiles. Controlled-release oxycodone has the advantage of less frequent dosing than immediate-release oxycodone however, other agents may be dosed infrequently at much lower costs. For patients requiring a controlled-release opioid treatment, controlled-release morphine and methadone should be considered because they appear to be as effective as oxycodone and cost considerably less. controlled-release oxycodone may be appropriate for some patients, particularly if they cannot tolerate other controlled-release or long-acting opioid analgesics.
引用
收藏
页码:898 / 904
页数:7
相关论文
共 26 条
[1]   The rediscovery of methadone for cancer pain management [J].
Ayonrinde, OT ;
Bridge, DT .
MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (10) :536-540
[2]   Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain [J].
Bruera, E ;
Belzile, M ;
Pituskin, E ;
Fainsinger, R ;
Darke, A ;
Harsanyi, Z ;
Babul, N ;
Ford, I .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3222-3229
[3]  
Caldwell JR, 1999, J RHEUMATOL, V26, P862
[4]  
CARDINALE V, 2001, DRUG TOPICS RED BOOK
[5]   Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model [J].
Curtis, GB ;
Johnson, GH ;
Clark, P ;
Taylor, R ;
Brown, J ;
O'Callaghan, R ;
Shi, M ;
Lacouture, PG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (06) :425-429
[6]   Reduction in constipation and laxative requirements following opioid rotation to methadone: A report of four cases [J].
Daeninck, PJ ;
Bruera, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (04) :303-309
[7]  
DEGRAZIA R, 2000, ANN M AM COLL RHEUM
[8]   Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain [J].
Gagnon, B ;
Bruera, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (02) :120-125
[9]   Methadone: Outpatient titration and monitoring strategies in cancer patients [J].
Hagen, NA ;
Wasylenko, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 18 (05) :369-375
[10]  
Hagen NA, 1997, CANCER-AM CANCER SOC, V79, P1428